UniProt ID | INT9_HUMAN | |
---|---|---|
UniProt AC | Q9NV88 | |
Protein Name | Integrator complex subunit 9 | |
Gene Name | INTS9 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 658 | |
Subcellular Localization | Nucleus . | |
Protein Description | Component of the Integrator (INT) complex, a complex involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing. The Integrator complex is associated with the C-terminal domain (CTD) of RNA polymerase II largest subunit (POLR2A) and is recruited to the U1 and U2 snRNAs genes (Probable). Mediates recruitment of cytoplasmic dynein to the nuclear envelope, probably as component of the INT complex. [PubMed: 23904267] | |
Protein Sequence | MKLYCLSGHPTLPCNVLKFKSTTIMLDCGLDMTSTLNFLPLPLVQSPRLSNLPGWSLKDGNAFLDKELKECSGHVFVDSVPEFCLPETELIDLSTVDVILISNYHCMMALPYITEHTGFTGTVYATEPTVQIGRLLMEELVNFIERVPKAQSASLWKNKDIQRLLPSPLKDAVEVSTWRRCYTMQEVNSALSKIQLVGYSQKIELFGAVQVTPLSSGYALGSSNWIIQSHYEKVSYVSGSSLLTTHPQPMDQASLKNSDVLVLTGLTQIPTANPDGMVGEFCSNLALTVRNGGNVLVPCYPSGVIYDLLECLYQYIDSAGLSSVPLYFISPVANSSLEFSQIFAEWLCHNKQSKVYLPEPPFPHAELIQTNKLKHYPSIHGDFSNDFRQPCVVFTGHPSLRFGDVVHFMELWGKSSLNTVIFTEPDFSYLEALAPYQPLAMKCIYCPIDTRLNFIQVSKLLKEVQPLHVVCPEQYTQPPPAQSHRMDLMIDCQPPAMSYRRAEVLALPFKRRYEKIEIMPELADSLVPMEIKPGISLATVSAVLHTKDNKHLLQPPPRPAQPTSGKKRKRVSDDVPDCKVLKPLLSGSIPVEQFVQTLEKHGFSDIKVEDTAKGHIVLLQEAETLIQIEEDSTHIICDNDEMLRVRLRDLVLKFLQKF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Ubiquitination | ------MKLYCLSGH ------CCEEECCCC | 48.43 | - | |
4 | Phosphorylation | ----MKLYCLSGHPT ----CCEEECCCCCC | 5.94 | 26503514 | |
18 | Ubiquitination | TLPCNVLKFKSTTIM CCCCCEEEECCCEEE | 46.60 | - | |
18 | Acetylation | TLPCNVLKFKSTTIM CCCCCEEEECCCEEE | 46.60 | 26051181 | |
21 | Phosphorylation | CNVLKFKSTTIMLDC CCEEEECCCEEEEEC | 33.64 | 24144214 | |
22 | Phosphorylation | NVLKFKSTTIMLDCG CEEEECCCEEEEECC | 22.41 | 24144214 | |
23 | Phosphorylation | VLKFKSTTIMLDCGL EEEECCCEEEEECCC | 16.10 | 24144214 | |
33 | Phosphorylation | LDCGLDMTSTLNFLP EECCCCCCCCCCCCC | 20.44 | 24144214 | |
34 | Ubiquitination | DCGLDMTSTLNFLPL ECCCCCCCCCCCCCC | 25.02 | 21890473 | |
34 | Ubiquitination | DCGLDMTSTLNFLPL ECCCCCCCCCCCCCC | 25.02 | 21890473 | |
34 | Phosphorylation | DCGLDMTSTLNFLPL ECCCCCCCCCCCCCC | 25.02 | 24144214 | |
35 | Phosphorylation | CGLDMTSTLNFLPLP CCCCCCCCCCCCCCC | 19.29 | 24144214 | |
42 | Ubiquitination | TLNFLPLPLVQSPRL CCCCCCCCCCCCCCH | 28.66 | 29967540 | |
46 | Phosphorylation | LPLPLVQSPRLSNLP CCCCCCCCCCHHCCC | 12.42 | 24144214 | |
58 | Ubiquitination | NLPGWSLKDGNAFLD CCCCCCCCCCCHHCC | 59.06 | 21890473 | |
58 | Ubiquitination | NLPGWSLKDGNAFLD CCCCCCCCCCCHHCC | 59.06 | 21906983 | |
58 | Sumoylation | NLPGWSLKDGNAFLD CCCCCCCCCCCHHCC | 59.06 | 28112733 | |
66 | Ubiquitination | DGNAFLDKELKECSG CCCHHCCHHHHHCCC | 68.07 | 29967540 | |
133 | Ubiquitination | TEPTVQIGRLLMEEL CCCCHHHHHHHHHHH | 9.33 | 29967540 | |
136 | Ubiquitination | TVQIGRLLMEELVNF CHHHHHHHHHHHHHH | 3.80 | 29967540 | |
149 | Ubiquitination | NFIERVPKAQSASLW HHHHHCCHHHCCHHH | 57.09 | - | |
157 | Ubiquitination | AQSASLWKNKDIQRL HHCCHHHCCCCHHHH | 60.45 | 29967540 | |
159 | Ubiquitination | SASLWKNKDIQRLLP CCHHHCCCCHHHHCC | 53.10 | - | |
167 | Phosphorylation | DIQRLLPSPLKDAVE CHHHHCCCCHHHCCH | 42.72 | 23403867 | |
170 | Ubiquitination | RLLPSPLKDAVEVST HHCCCCHHHCCHHHC | 47.20 | - | |
177 | Phosphorylation | KDAVEVSTWRRCYTM HHCCHHHCHHHCCCH | 28.32 | 24719451 | |
330 | Ubiquitination | SVPLYFISPVANSSL CCCEEEECCCCCCCC | 11.92 | 29967540 | |
333 | Ubiquitination | LYFISPVANSSLEFS EEEECCCCCCCCHHH | 17.36 | 29967540 | |
348 | Ubiquitination | QIFAEWLCHNKQSKV HHHHHHHHCCCCCCE | 3.31 | 29967540 | |
351 | Ubiquitination | AEWLCHNKQSKVYLP HHHHHCCCCCCEECC | 32.08 | 29967540 | |
354 | Ubiquitination | LCHNKQSKVYLPEPP HHCCCCCCEECCCCC | 32.19 | 29967540 | |
372 | Ubiquitination | AELIQTNKLKHYPSI HHHHCCCCCCCCCCC | 63.40 | 29967540 | |
374 | Ubiquitination | LIQTNKLKHYPSIHG HHCCCCCCCCCCCCC | 42.58 | - | |
399 | Phosphorylation | VVFTGHPSLRFGDVV EEEECCCCCCCCCHH | 26.88 | 24719451 | |
414 | Ubiquitination | HFMELWGKSSLNTVI HHHHHHCCCCCCEEE | 25.86 | 21890473 | |
435 | Ubiquitination | SYLEALAPYQPLAMK HHHHHHCCCCCCEEE | 29.19 | 21890473 | |
435 | Ubiquitination | SYLEALAPYQPLAMK HHHHHHCCCCCCEEE | 29.19 | 21890473 | |
438 | Ubiquitination | EALAPYQPLAMKCIY HHHCCCCCCEEEEEE | 19.08 | 21890473 | |
438 | Ubiquitination | EALAPYQPLAMKCIY HHHCCCCCCEEEEEE | 19.08 | 21890473 | |
441 | Ubiquitination | APYQPLAMKCIYCPI CCCCCCEEEEEECCC | 4.85 | 29967540 | |
459 | Ubiquitination | LNFIQVSKLLKEVQP CCHHHHHHHHHHHCC | 60.01 | 33845483 | |
462 | Ubiquitination | IQVSKLLKEVQPLHV HHHHHHHHHHCCCEE | 67.29 | 29967540 | |
465 | Ubiquitination | SKLLKEVQPLHVVCP HHHHHHHCCCEEECH | 35.61 | 21890473 | |
486 | Ubiquitination | PPAQSHRMDLMIDCQ CCCCCCCCCEEEECC | 3.77 | 21890473 | |
486 | Ubiquitination | PPAQSHRMDLMIDCQ CCCCCCCCCEEEECC | 3.77 | 21890473 | |
489 | Ubiquitination | QSHRMDLMIDCQPPA CCCCCCEEEECCCCC | 1.80 | 21890473 | |
489 | Ubiquitination | QSHRMDLMIDCQPPA CCCCCCEEEECCCCC | 1.80 | 21890473 | |
510 | Ubiquitination | EVLALPFKRRYEKIE HHHCCCCHHHHHCCC | 33.74 | 29967540 | |
539 | Phosphorylation | KPGISLATVSAVLHT CCCCEEEEEEEEEEC | 21.93 | - | |
555 | Ubiquitination | DNKHLLQPPPRPAQP CCCCCCCCCCCCCCC | 40.61 | 33845483 | |
558 | Ubiquitination | HLLQPPPRPAQPTSG CCCCCCCCCCCCCCC | 44.98 | 33845483 | |
563 | Phosphorylation | PPRPAQPTSGKKRKR CCCCCCCCCCCCCCC | 37.72 | 30266825 | |
564 | Phosphorylation | PRPAQPTSGKKRKRV CCCCCCCCCCCCCCC | 56.13 | 30266825 | |
566 | Acetylation | PAQPTSGKKRKRVSD CCCCCCCCCCCCCCC | 49.53 | 25953088 | |
569 | Ubiquitination | PTSGKKRKRVSDDVP CCCCCCCCCCCCCCC | 67.06 | - | |
572 | Phosphorylation | GKKRKRVSDDVPDCK CCCCCCCCCCCCCCC | 31.93 | 25159151 | |
576 | Ubiquitination | KRVSDDVPDCKVLKP CCCCCCCCCCCHHHH | 48.56 | 33845483 | |
579 | Ubiquitination | SDDVPDCKVLKPLLS CCCCCCCCHHHHHHC | 58.96 | 33845483 | |
582 | Ubiquitination | VPDCKVLKPLLSGSI CCCCCHHHHHHCCCC | 36.29 | - | |
583 | Ubiquitination | PDCKVLKPLLSGSIP CCCCHHHHHHCCCCC | 34.08 | 29967540 | |
586 | Ubiquitination | KVLKPLLSGSIPVEQ CHHHHHHCCCCCHHH | 37.87 | 29967540 | |
600 | Ubiquitination | QFVQTLEKHGFSDIK HHHHHHHHCCCCCEE | 52.74 | 33845483 | |
607 | Ubiquitination | KHGFSDIKVEDTAKG HCCCCCEEEEECCCC | 44.56 | 29967540 | |
626 | Ubiquitination | LQEAETLIQIEEDST EEECEEEEEECCCCC | 5.18 | 21890473 | |
629 | Ubiquitination | AETLIQIEEDSTHII CEEEEEECCCCCEEE | 39.10 | 21890473 | |
629 | Ubiquitination | AETLIQIEEDSTHII CEEEEEECCCCCEEE | 39.10 | 21890473 | |
632 | Ubiquitination | LIQIEEDSTHIICDN EEEECCCCCEEEECC | 25.76 | 21890473 | |
632 | Ubiquitination | LIQIEEDSTHIICDN EEEECCCCCEEEECC | 25.76 | 21890473 | |
647 | Ubiquitination | DEMLRVRLRDLVLKF HHHHHHHHHHHHHHH | 4.58 | 21890473 | |
650 | Ubiquitination | LRVRLRDLVLKFLQK HHHHHHHHHHHHHHH | 3.82 | 21890473 | |
653 | Ubiquitination | RLRDLVLKFLQKF-- HHHHHHHHHHHHC-- | 36.23 | 21890473 | |
671 | Ubiquitination | -------------------- -------------------- | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of INT9_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of INT9_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of INT9_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
INT11_HUMAN | CPSF3L | physical | 26344197 | |
INT5_HUMAN | INTS5 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...